Ketogenic Diet for Traumatic Brain Injury
Trial Summary
What is the purpose of this trial?
Traumatic Brain Injury (TBI) represents a significant public health risk in the United States leaving many survivors with significant long term cognitive deficits and at risk for neurodegenerative diseases. Despite extensive research there are no pharmacological therapies which have demonstrated significant improvement in neurological or cognitive recovery. Changes in glucose metabolism are considered the hallmark metabolic response to TBI and ketosis has been proposed as a therapy to ameliorate metabolic dysfunction. This trial investigates the therapeutic potential of a ketogenic or modified Atkins diet on neurocognitive outcome following moderate-severe TBI.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the ketogenic diet as a treatment for traumatic brain injury?
Is the ketogenic diet generally safe for humans?
The ketogenic diet has been studied for its safety and potential benefits in various conditions, including traumatic brain injury. While specific safety data for adults with traumatic brain injury is limited, the diet is generally considered safe for humans, though it may have side effects like nutrient deficiencies and gastrointestinal issues. Always consult with a healthcare provider before starting any new diet.12356
How does the ketogenic diet treatment differ from other treatments for traumatic brain injury?
The ketogenic diet is unique for traumatic brain injury as it shifts the body's energy source from carbohydrates to fats, producing ketones that may protect brain cells and improve recovery. Unlike other treatments, it has shown potential in reducing brain tissue loss and inflammation, and enhancing functional outcomes, particularly in cases where standard treatments are lacking.12357
Research Team
Duc Tran, MD
Principal Investigator
Loma LInda University Medical Center
Brenda Bartnik-Olson, PhD
Principal Investigator
Loma LInda University Medical Center
Eligibility Criteria
This trial is for individuals with moderate to severe traumatic brain injury (TBI) admitted to Loma Linda University's surgical intensive care unit. Eligible participants are those within 2-30 days post-injury but not pregnant, without severe speech issues, significant prior neurological disorders or interventions, acute intoxication at the time of injury, certain metabolic disorders that conflict with a ketogenic diet, history of serious mental illness, renal failure, abdominal surgery during admission, Type 1 diabetes or liver dysfunction.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a ketogenic or modified Atkins diet to assess its impact on neurocognitive and neurological outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of cognitive and neurological outcomes
Treatment Details
Interventions
- Ketogenic Diet
- Ketogenic/Modified Atkins Diet
- Standard Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loma Linda University
Lead Sponsor